Literature DB >> 3337945

Prognostic significance of DNA ploidy in colorectal cancer: a prospective flow cytometric study.

D J Jones1, M Moore, P F Schofield.   

Abstract

A prospective study of prognostic factors has been carried out in a group of 123 consecutive patients with colorectal cancer. The fate of all patients is known at 3 years after operation. Clinical and pathological data were recorded at the time of presentation and operation, and the patients have been subject to regular postoperative review. DNA ploidy status was determined by flow cytometry. In all, 39 (33 per cent) patients had DNA diploid tumours and 80 (67 per cent) patients had DNA aneuploid tumours. In four cases, tumour material was not obtained. The patients with DNA aneuploid tumours had a worse prognosis than those with DNA diploid tumours, but this was only seen in those patients classified as Dukes' B. In a Cox's regression analysis, the surgeon's assessment of operability was the strongest predictor of survival, followed by the pathological classification and the patient's age. After these factors had been considered, the DNA ploidy status conferred no independent survival value.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3337945     DOI: 10.1002/bjs.1800750111

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  18 in total

1.  Comparison of deoxyribonucleic acid ploidy and nuclear expressed p62 c-myc oncogene in the prognosis of colorectal cancer.

Authors:  S Rowley; K M Newbold; J Gearty; M R Keighley; I A Donovan; J P Neoptolemos
Journal:  World J Surg       Date:  1990 Jul-Aug       Impact factor: 3.352

Review 2.  Anastomosis or stoma for low rectal cancer?

Authors:  C Hall; S Rowley; J P Neoptolemos
Journal:  Postgrad Med J       Date:  1989-03       Impact factor: 2.401

Review 3.  Genetics of colon cancer.

Authors:  D J Ahnen
Journal:  West J Med       Date:  1991-06

4.  Flow cytometric analysis in colorectal carcinoma: prognostic significance of cellular DNA content.

Authors:  A Schillaci; D D Tirindelli; M Ferri; L Teodori; F Mauro; V Nicolanti; S Stipa
Journal:  Int J Colorectal Dis       Date:  1990-12       Impact factor: 2.571

5.  Flow cytometry in colon cancer: does flow cytometric cell cycle analysis help predict for short-term recurrence in patients with colorectal carcinoma?

Authors:  C Hixon; J Furlong; A Silbergleit
Journal:  J Natl Med Assoc       Date:  1995-11       Impact factor: 1.798

6.  DNA content and MHC class II antigen expression in malignant melanoma: clinical course.

Authors:  J Zaloudik; M Moore; A K Ghosh; Z Mechl; A Rejthar
Journal:  J Clin Pathol       Date:  1988-10       Impact factor: 3.411

7.  Pancreatic cancer cell DNA content correlates with long-term survival after pancreatoduodenectomy.

Authors:  D C Allison; K K Bose; R H Hruban; S Piantadosi; W C Dooley; J K Boitnott; J L Cameron
Journal:  Ann Surg       Date:  1991-12       Impact factor: 12.969

8.  The prognostic value of nucleolar organiser regions in colorectal cancer: a 5-year follow-up study.

Authors:  W P Joyce; M Fynes; K T Moran; D B Gough; P Dervan; T F Gorey; J M Fitzpatrick
Journal:  Ann R Coll Surg Engl       Date:  1992-05       Impact factor: 1.891

9.  Prognostic significance of tumor markers in colorectal cancer patients: DNA index, S-phase fraction, p53 expression, and Ki-67 index.

Authors:  Y T Chen; M J Henk; K J Carney; W D Wong; D A Rothenberger; T Zheng; M Feygin; R D Madoff
Journal:  J Gastrointest Surg       Date:  1997 May-Jun       Impact factor: 3.452

10.  Heterogeneity in ploidy and S-phase fraction in colorectal adenocarcinomas.

Authors:  G Lindmark; B Glimelius; L Påhlman; P Enblad
Journal:  Int J Colorectal Dis       Date:  1991-05       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.